Their company died. Their antimalarial drug lives on — with hopes of saving millions of lives

Atreca’s antibody discovery work goes back to 2012, after it spun out of work at a Stanford University lab and the Bill & Melinda Gates Foundation ponied up the first “serious money.”
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks